Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data

BACKGROUND: The surveillance of drug resistance among tuberculosis (TB) patients is central to combatting the global TB epidemic and preventing the spread of antimicrobial resistance. Isoniazid and rifampicin are two of the most powerful first-line anti-TB medicines, and resistance to either of them...

Descripción completa

Detalles Bibliográficos
Autores principales: Dean, Anna S., Zignol, Matteo, Cabibbe, Andrea Maurizio, Falzon, Dennis, Glaziou, Philippe, Cirillo, Daniela Maria, Köser, Claudio U., Gonzalez-Angulo, Lice Y., Tosas-Auget, Olga, Ismail, Nazir, Tahseen, Sabira, Ama, Maria Cecilia G., Skrahina, Alena, Alikhanova, Natavan, Kamal, S. M. Mostofa, Floyd, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974034/
https://www.ncbi.nlm.nih.gov/pubmed/31961877
http://dx.doi.org/10.1371/journal.pmed.1003008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974034/
https://www.ncbi.nlm.nih.gov/pubmed/31961877
http://dx.doi.org/10.1371/journal.pmed.1003008

Ejemplares similares